All times indicated in CET

Thursday 24 September 2020
12:45 – 13:45

The journey ahead:
Reimagining the future of cystic fibrosis in an era of precision therapies
Moderator: Isabelle Fajac, Paris, FR 
12:45 – 12:50Welcome and introduction -Isabelle Fajac, Paris, FR 
12:50 – 12:55The future of CF in perspective  – Isabelle Fajac, Paris, FR 
12:55 – 13:05The evolving natural history of CF - Ed McKone, Dublin, IE
13:05 – 13:20Rethinking care for an ageing community - Barry Plant, Cork, IE
13:20 – 13:30A changing landscape in CF: challenges and opportunities to optimise care provision - Daniel Peckham, Leeds, UK
13:30 – 13:45 Panel discussion and Q&A - Isabelle Fajac, Paris, FR

Thursday 24 September 2020
17:45 - 18:45 

Cystic fibrosis multidisciplinary care: a holistic approach

17:45 – 17:50Introduction - Nichola MacDuff, Wolverhampton, UK
17:50 – 18:00The clinical perspective of today’s cystic fibrosis care modalities - Benedetta Fabrizzi, Ancona, IT
18:00 – 18:10The broadened role of physiotherapy in today’s cystic fibrosis management - Hugues Gauchez, Lille, FR
18:10 – 18:20Cystic fibrosis care and the patient, a holistic approach from the nurses’ view - Nichola MacDuff, Wolverhampton, UK
18:20 – 18:30A patient’s view of current and future needs in cystic fibrosis care - Tim Wotton, Wimbledon, GB
18:30 – 18:45Q&A and close - Nichola MacDuff, Wolverhampton, UK

This is a non-promotional meeting organized and funded by F. Hoffmann-La Roche Ltd. that is intended for healthcare professionals outside of the USA. It may include scientific information about investigational compounds that are not approved or valid in your jurisdiction

Friday 25 September 2020
07:45 - 08:45 

Current & future strategies in an evolving Cystic Fibrosis treatment landscape
Moderator: Isabelle Sermet-Gaudelus, Paris, FR

07:45 – 07:50Introduction
Isabelle Sermet-Gaudelus, Paris, FR
07:50 – 08:03Real-life approaches to managing P. aeruginosa infections in cystic fibrosis
Carsten Schwarz, Berlin, DE
08:03 – 08:16 The future of antibiotics in an era of new therapies in cystic fibrosis
Barry Plant, Cork, IE
08:16 – 08:29In the future, what approaches can be used to address treatment burden in cystic fibrosis?
Christophe Marguet, Rouen, FR
08:30 – 08:45Q&A and closing

Friday 25 September 2020
12:45 - 13:45 

The importance of Inhaled antibiotics in the age of disease modifiers

12:45 – 12:50Welcome and introductions 
Daniel Peckham, Leeds, UK
12:50 – 13:10Changes in microbiology and treatment after the introduction of CFTR modulators 
Harry Heijerman, Utrecht, the Netherlands
13:10 – 13:30 The role of inhaled antibiotics in cystic fibrosis 
Daniel Peckham, Leeds, UK 
13:30 – 13:45Q&A, summary and meeting close 
Daniel Peckham, Leeds, UK 

Friday 25 September 2020
17:45 - 18:45 

Completing the journey for all patients
Moderator: Marcus Mall, Berlin, Germany

17:45 – 17:50Welcome and introduction - Marcus Mall, Berlin, DE
17:50 – 18:00Completing the picture in cystic fibrosis (CF): challenges and opportunities
Marcus Mall, Berlin, DE
18:00 – 18:15 Tuning in to the right channel – what have we learnt from CFTR?
Paul Negulescu, Vertex Pharmaceuticals, San Diego, US
18:15 – 18:30Beyond F508del: getting to all CF mutations
Frederick Van Goor, Vertex Pharmaceuticals, San Diego, US
18:30 – 18:45Panel discussion and Q&A
Marcus Mall, Berlin, DE